Aphios

About:

Aphios, a green biotechnology company, develops technology platforms for drug discovery, delivery, and safety.

Website: http://www.aphios.com

Twitter/X: aphios

Top Investors: National Institutes of Health, Citizens Bank

Description:

Aphios Corporation, a green biotechnology company is developing enabling technology platforms designed to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Using these enabling technology platforms, Aphios® and its collaborators are developing enhanced therapeutics for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders.

Total Funding Amount:

$2.42M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

1993-01-01

Contact Email:

aphios(AT)aphios.com

Founders:

Trevor Castor

Number of Employees:

11-50

Last Funding Date:

2023-05-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai